These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3383543)

  • 1. Effect of four intravenous infusion methods on tobramycin pharmacokinetics.
    Pleasants RA; Sawyer WT; Williams DM; McKenna WR; Powell JR
    Clin Pharm; 1988 May; 7(5):374-9. PubMed ID: 3383543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of tobramycin delivery by four i.v. infusion methods.
    Pleasants RA; Sawyer WT; Williams DM; McKenna WR; Brown JM; Powell JR
    Clin Pharm; 1988 May; 7(5):367-73. PubMed ID: 3383542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tobramycin in cats.
    Jernigan AD; Hatch RC; Wilson RC
    Am J Vet Res; 1988 May; 49(5):608-12. PubMed ID: 3395005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various storage conditions on a fluorescence polarization immunoassay for tobramycin.
    Cohen IA; DeKeyser JM; Hyder DM
    Am J Hosp Pharm; 1985 Mar; 42(3):605-9. PubMed ID: 3985025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of infusion systems on pharmacokinetic parameters of tobramycin in newborn infants.
    Nahata MC
    Chemotherapy; 1988; 34(5):361-6. PubMed ID: 3180903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
    Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG
    Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.
    Rodvold KA; Blum RA
    J Clin Pharmacol; 1987; 27(5):419-24. PubMed ID: 3693587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tobramycin in ducks and sex-related differences.
    Dimitrova D; Moutafchieva R; Kanelov I; Dinev T; Lashev L
    Vet J; 2009 Mar; 179(3):462-4. PubMed ID: 18006340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gentamicin pharmacokinetics during the perioperative period.
    Kloth DD; Tegtmeier BR; Kong C; Akahoshi MP; Leach SH; Beatty JD; Zaia JA
    Clin Pharm; 1985; 4(2):182-5. PubMed ID: 3987217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Build up of a given concentration of tobramycin and sisomycin in the blood of young children by the intravenous infusion of the antibiotics according to a calculated regimen].
    Firsov AA; Pankova GF
    Antibiotiki; 1982 Nov; 27(11):830-5. PubMed ID: 6758682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The administration of tobramycin in the 2nd and 3rd trimester of pregnancy: contribution to a pharmacokinetic study for the adaptation of posology].
    Fernandez H; Bourget P; Delouis C; Demirdjian S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(1):107-15. PubMed ID: 2019711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release infusion kinetics of tobramycin.
    Lane JR; Murray WE; Willenborg NL; Wilcox CL; Connor JD; Adler DS
    Ther Drug Monit; 1989; 11(3):264-8. PubMed ID: 2728084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.